Vemzatatug
Vemzatatug is a humanized IgG1κ monoclonal antibody inhibitor targeting GPRC5D. Vemzatatug has an antitumor activity. Vemzatatug can be used for cancers like multiple myeloma (MM) research[1][2].
Product Specifications
CAS Number
3035714-52-1
UNSPSC
12352100
Target
Orphan GPCR
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Rodriguez-Otero P, et al. GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood Cancer J. 2024 Feb 2;14 (1) :24. doi: 10.1038/s41408-023-00966-9. Erratum in: Blood Cancer J. 2024 Mar 6;14 (1) :40. |[2]Internacionales D C. International Nonproprietary Names for Pharmaceutical Substances (INN) [J]. WHO Drug Information, 2025, 39 (2) .
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV725891 1.0 µg DNA
FRA9D Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
TL710179V 500 µL Each
Aqp8 Rat shRNA Lentiviral Particle (Locus ID 29172)
Sign In for Pricing
View Details 
QP7215-ec-50ug 50ug
Recombinant UDP-3-O-acyl-N-acetylglucosamine deacetylase Protein, His-SUMO, E.coli-50ug
Sign In for Pricing
View Details 